Try our Advanced Search for more refined results

West Virginia Pipe Trades Health & Welfare Fund v. Medtronic, Inc. et al

  1. October 30, 2018

    Investor Attys Seek $8.5M In $43M Medtronic Stock-Drop Deal

    Counsel for a class of Medtronic Inc. investors asked a Minnesota federal judge on Monday for $8.5 million in fees and expenses for their work in reaching a $43 million settlement over claims the medical device maker manipulated studies for one of its products.

  2. July 19, 2018

    Medtronic Strikes $43M Deal To End Stock-Drop Suit

    Medtronic Inc. investors asked a Minnesota federal judge on Wednesday for initial approval of a $43 million settlement they reached with the medical device maker after five years of litigation involving claims it manipulated studies for a bone graft product to drive up share prices.

  3. January 30, 2018

    Medtronic Investors Win Cert. In Revived Stock-Drop Suit

    A Minnesota federal judge Tuesday granted a class of Medtronic Inc. investors' bid for certification in their renewed suit alleging the company downplayed problems with its bone graft products and paid hundreds of millions of dollars to authors of studies with the end goal of driving up its stock price.

  4. September 30, 2015

    Medtronic Escapes Investors' Claims Of Tainted Studies

    A Minnesota federal judge on Wednesday tossed the remainder of a securities class action alleging Medtronic Inc. downplayed problems with its bone graft products and manipulated studies to drive up its stock price, ruling some claims were time-barred, after the judge trimmed the suit about a year ago.

  5. September 29, 2014

    Medtronic Can't Shake Investors' Claims Of Tainted Studies

    A Minnesota federal judge on Monday refused to throw out the bulk of a securities class action alleging Medtronic Inc. downplayed problems with its bone graft products, saying the investors' allegations that the medical device maker manipulated studies to drive up its stock price are adequate.

  6. June 28, 2013

    Medtronic Hit With Shareholder Suit Over Infuse Studies

    Medical device maker Medtronic Inc. helped researchers downplay the risks and side effects of its Infuse bone graft product, causing its stock price to fall when the scheme was revealed, a Minnesota securities class action filed Thursday alleges.